Pharmaceutical Market in Canada 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	148 Pages	TechNavio	March, 2024	INF18655869

Best Price Guarantee
Price	from $2,500
Length	148 Pages
Publisher	TechNavio
Published Date	March, 2024
SKU	INF18655869

Pharmaceutical Market In Canada 2024-2028

The pharmaceutical market in Canada is forecasted to grow by USD 8.73 bn during 2023-2028, accelerating at a CAGR of 4.6% during the forecast period. The report on the pharmaceutical market in Canada provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high investment in pharmaceutical industry, increasing geriatric population in Canada, and rising occurrence of chronic diseases in Canada.

Technavio's pharmaceutical market in Canada is segmented as below:

By Distribution Channel

Pharmacy
Clinic

By Type

Prescription
Non-prescription

By Therapy Area

Musculoskeletal system
Nervous system
Respiratory system
Others

By Geographical Landscape

North America

This study identifies the increasing advancements in biotechnology as one of the prime reasons driving the pharmaceutical market in Canada growth during the next few years. Also, digital health integration in pharmaceutical market in Canada and heightened focus on R and D for rare diseases will lead to sizable demand in the market.

The report on the pharmaceutical market in Canada covers the following areas:

Pharmaceutical market in Canada sizing
Pharmaceutical market in Canada forecast
Pharmaceutical market in Canada industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pharmaceutical market in Canada vendors that include Abbott Laboratories, AbbVie Inc., Amgen Inc., Apotex Inc., AstraZeneca PLC, Bayer AG, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Eli Lilly and Co., F. Hoffmann La Roche Ltd., Gilead Sciences Inc., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., LES LABORATOIRES SERVIER, Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Sun Pharmaceutical Industries Ltd., and Teva Pharmaceutical Industries Ltd.. Also, the pharmaceutical market in Canada analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibit 05: Executive Summary - Chart on Market Segmentation by Type; Exhibit 06: Executive Summary - Chart on Market Segmentation by Therapy Area; Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 08: Parent market; Exhibit 09: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 10: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 11: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 12: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibit 13: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibit 14: Chart on Canada: Year-over-year growth 2023-2028 (%); Exhibit 15: Data Table on Canada: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Pharmaceutical market in Canada 2018 - 2022; Exhibit 16: Historic Market Size - Data Table on pharmaceutical market in Canada 2018 - 2022 ($ billion); 4.2 Distribution Channel Segment Analysis 2018 - 2022; Exhibit 17: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); 4.3 Type Segment Analysis 2018 - 2022; Exhibit 18: Historic Market Size - Type Segment 2018 - 2022 ($ billion); 4.4 Therapy Area Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Therapy Area Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 20: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Distribution Channel: 6.1 Market segments; Exhibit 27: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibit 28: Data Table on Distribution Channel - Market share 2023-2028 (%); 6.2 Comparison by Distribution Channel; Exhibit 29: Chart on Comparison by Distribution Channel; Exhibit 30: Data Table on Comparison by Distribution Channel; 6.3 Pharmacy - Market size and forecast 2023-2028; Exhibit 31: Chart on Pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 32: Data Table on Pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibit 33: Chart on Pharmacy - Year-over-year growth 2023-2028 (%); Exhibit 34: Data Table on Pharmacy - Year-over-year growth 2023-2028 (%); 6.4 Clinic - Market size and forecast 2023-2028; Exhibit 35: Chart on Clinic - Market size and forecast 2023-2028 ($ billion); Exhibit 36: Data Table on Clinic - Market size and forecast 2023-2028 ($ billion); Exhibit 37: Chart on Clinic - Year-over-year growth 2023-2028 (%); Exhibit 38: Data Table on Clinic - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by Distribution Channel; Exhibit 39: Market opportunity by Distribution Channel ($ billion); Exhibit 40: Data Table on Market opportunity by Distribution Channel ($ billion)
7 Market Segmentation by Type: 7.1 Market segments; Exhibit 41: Chart on Type - Market share 2023-2028 (%); Exhibit 42: Data Table on Type - Market share 2023-2028 (%); 7.2 Comparison by Type; Exhibit 43: Chart on Comparison by Type; Exhibit 44: Data Table on Comparison by Type; 7.3 Prescription - Market size and forecast 2023-2028; Exhibit 45: Chart on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibit 46: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibit 47: Chart on Prescription - Year-over-year growth 2023-2028 (%); Exhibit 48: Data Table on Prescription - Year-over-year growth 2023-2028 (%); 7.4 Non-prescription - Market size and forecast 2023-2028; Exhibit 49: Chart on Non-prescription - Market size and forecast 2023-2028 ($ billion); Exhibit 50: Data Table on Non-prescription - Market size and forecast 2023-2028 ($ billion); Exhibit 51: Chart on Non-prescription - Year-over-year growth 2023-2028 (%); Exhibit 52: Data Table on Non-prescription - Year-over-year growth 2023-2028 (%); 7.5 Market opportunity by Type; Exhibit 53: Market opportunity by Type ($ billion); Exhibit 54: Data Table on Market opportunity by Type ($ billion)
8 Market Segmentation by Therapy Area: 8.1 Market segments; Exhibit 55: Chart on Therapy Area - Market share 2023-2028 (%); Exhibit 56: Data Table on Therapy Area - Market share 2023-2028 (%); 8.2 Comparison by Therapy Area; Exhibit 57: Chart on Comparison by Therapy Area; Exhibit 58: Data Table on Comparison by Therapy Area; 8.3 Musculoskeletal system - Market size and forecast 2023-2028; Exhibit 59: Chart on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion); Exhibit 60: Data Table on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion); Exhibit 61: Chart on Musculoskeletal system - Year-over-year growth 2023-2028 (%); Exhibit 62: Data Table on Musculoskeletal system - Year-over-year growth 2023-2028 (%); 8.4 Nervous system - Market size and forecast 2023-2028; Exhibit 63: Chart on Nervous system - Market size and forecast 2023-2028 ($ billion); Exhibit 64: Data Table on Nervous system - Market size and forecast 2023-2028 ($ billion); Exhibit 65: Chart on Nervous system - Year-over-year growth 2023-2028 (%); Exhibit 66: Data Table on Nervous system - Year-over-year growth 2023-2028 (%); 8.5 Respiratory system - Market size and forecast 2023-2028; Exhibit 67: Chart on Respiratory system - Market size and forecast 2023-2028 ($ billion); Exhibit 68: Data Table on Respiratory system - Market size and forecast 2023-2028 ($ billion); Exhibit 69: Chart on Respiratory system - Year-over-year growth 2023-2028 (%); Exhibit 70: Data Table on Respiratory system - Year-over-year growth 2023-2028 (%); 8.6 Others - Market size and forecast 2023-2028; Exhibit 71: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibit 72: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibit 73: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Others - Year-over-year growth 2023-2028 (%); 8.7 Market opportunity by Therapy Area; Exhibit 75: Market opportunity by Therapy Area ($ billion); Exhibit 76: Data Table on Market opportunity by Therapy Area ($ billion)
9 Customer Landscape: 9.1 Customer landscape overview; Exhibit 77: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 78: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 79: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 80: Overview on factors of disruption; 11.4 Industry risks; Exhibit 81: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 82: Vendors covered; 12.2 Market positioning of vendors; Exhibit 83: Matrix on vendor position and classification; 12.3 Abbott Laboratories; Exhibit 84: Abbott Laboratories - Overview; Exhibit 85: Abbott Laboratories - Business segments; Exhibit 86: Abbott Laboratories - Key offerings; Exhibit 87: Abbott Laboratories - Segment focus; 12.4 AbbVie Inc.; Exhibit 88: AbbVie Inc. - Overview; Exhibit 89: AbbVie Inc. - Product / Service; Exhibit 90: AbbVie Inc. - Key news; Exhibit 91: AbbVie Inc. - Key offerings; 12.5 AstraZeneca PLC; Exhibit 92: AstraZeneca PLC - Overview; Exhibit 93: AstraZeneca PLC - Product / Service; Exhibit 94: AstraZeneca PLC - Key news; Exhibit 95: AstraZeneca PLC - Key offerings; 12.6 Bayer AG; Exhibit 96: Bayer AG - Overview; Exhibit 97: Bayer AG - Business segments; Exhibit 98: Bayer AG - Key news; Exhibit 99: Bayer AG - Key offerings; Exhibit 100: Bayer AG - Segment focus; 12.7 Boehringer Ingelheim International GmbH; Exhibit 101: Boehringer Ingelheim International GmbH - Overview; Exhibit 102: Boehringer Ingelheim International GmbH - Business segments; Exhibit 103: Boehringer Ingelheim International GmbH - Key news; Exhibit 104: Boehringer Ingelheim International GmbH - Key offerings; Exhibit 105: Boehringer Ingelheim International GmbH - Segment focus; 12.8 Bristol-Myers Squibb Company; Exhibit 106: Bristol-Myers Squibb Company - Overview; Exhibit 107: Bristol-Myers Squibb Company - Product / Service; Exhibit 108: Bristol-Myers Squibb Company - Key news; Exhibit 109: Bristol-Myers Squibb Company - Key offerings; 12.9 Eli Lilly and Co.; Exhibit 110: Eli Lilly and Co. - Overview; Exhibit 111: Eli Lilly and Co. - Product / Service; Exhibit 112: Eli Lilly and Co. - Key news; Exhibit 113: Eli Lilly and Co. - Key offerings; 12.10 F. Hoffmann La Roche Ltd.; Exhibit 114: F. Hoffmann La Roche Ltd. - Overview; Exhibit 115: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 116: F. Hoffmann La Roche Ltd. - Key news; Exhibit 117: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 118: F. Hoffmann La Roche Ltd. - Segment focus; 12.11 GlaxoSmithKline Plc; Exhibit 119: GlaxoSmithKline Plc - Overview; Exhibit 120: GlaxoSmithKline Plc - Business segments; Exhibit 121: GlaxoSmithKline Plc - Key news; Exhibit 122: GlaxoSmithKline Plc - Key offerings; Exhibit 123: GlaxoSmithKline Plc - Segment focus; 12.12 Johnson and Johnson Services Inc.; Exhibit 124: Johnson and Johnson Services Inc. - Overview; Exhibit 125: Johnson and Johnson Services Inc. - Business segments; Exhibit 126: Johnson and Johnson Services Inc. - Key news; Exhibit 127: Johnson and Johnson Services Inc. - Key offerings; Exhibit 128: Johnson and Johnson Services Inc. - Segment focus; 12.13 Merck and Co. Inc.; Exhibit 129: Merck and Co. Inc. - Overview; Exhibit 130: Merck and Co. Inc. - Business segments; Exhibit 131: Merck and Co. Inc. - Key news; Exhibit 132: Merck and Co. Inc. - Key offerings; Exhibit 133: Merck and Co. Inc. - Segment focus; 12.14 Novartis AG; Exhibit 134: Novartis AG - Overview; Exhibit 135: Novartis AG - Business segments; Exhibit 136: Novartis AG - Key news; Exhibit 137: Novartis AG - Key offerings; Exhibit 138: Novartis AG - Segment focus; 12.15 Pfizer Inc.; Exhibit 139: Pfizer Inc. - Overview; Exhibit 140: Pfizer Inc. - Product / Service; Exhibit 141: Pfizer Inc. - Key news; Exhibit 142: Pfizer Inc. - Key offerings; 12.16 Sanofi SA; Exhibit 143: Sanofi SA - Overview; Exhibit 144: Sanofi SA - Business segments; Exhibit 145: Sanofi SA - Key news; Exhibit 146: Sanofi SA - Key offerings; Exhibit 147: Sanofi SA - Segment focus; 12.17 Teva Pharmaceutical Industries Ltd.; Exhibit 148: Teva Pharmaceutical Industries Ltd. - Overview; Exhibit 149: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibit 150: Teva Pharmaceutical Industries Ltd. - Key news; Exhibit 151: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibit 152: Teva Pharmaceutical Industries Ltd. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 153: Inclusions checklist; Exhibit 154: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 155: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 156: Research methodology; Exhibit 157: Validation techniques employed for market sizing; Exhibit 158: Information sources; 13.5 List of abbreviations; Exhibit 159: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Distribution Channel; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by Therapy Area; Exhibits7: Executive Summary - Chart on Vendor Market Positioning; Exhibits8: Parent market; Exhibits9: Market Characteristics; Exhibits10: Offerings of vendors included in the market definition; Exhibits11: Market segments; Exhibits12: Chart on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits13: Data Table on Canada - Market size and forecast 2023-2028 ($ billion); Exhibits14: Chart on Canada: Year-over-year growth 2023-2028 (%); Exhibits15: Data Table on Canada: Year-over-year growth 2023-2028 (%); Exhibits16: Historic Market Size - Data Table on pharmaceutical market in Canada 2018 - 2022 ($ billion); Exhibits17: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion); Exhibits18: Historic Market Size - Type Segment 2018 - 2022 ($ billion); Exhibits19: Historic Market Size - Therapy Area Segment 2018 - 2022 ($ billion); Exhibits20: Five forces analysis - Comparison between 2023 and 2028; Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits23: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits24: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits25: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits26: Chart on Market condition - Five forces 2023 and 2028; Exhibits27: Chart on Distribution Channel - Market share 2023-2028 (%); Exhibits28: Data Table on Distribution Channel - Market share 2023-2028 (%); Exhibits29: Chart on Comparison by Distribution Channel; Exhibits30: Data Table on Comparison by Distribution Channel; Exhibits31: Chart on Pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits32: Data Table on Pharmacy - Market size and forecast 2023-2028 ($ billion); Exhibits33: Chart on Pharmacy - Year-over-year growth 2023-2028 (%); Exhibits34: Data Table on Pharmacy - Year-over-year growth 2023-2028 (%); Exhibits35: Chart on Clinic - Market size and forecast 2023-2028 ($ billion); Exhibits36: Data Table on Clinic - Market size and forecast 2023-2028 ($ billion); Exhibits37: Chart on Clinic - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Clinic - Year-over-year growth 2023-2028 (%); Exhibits39: Market opportunity by Distribution Channel ($ billion); Exhibits40: Data Table on Market opportunity by Distribution Channel ($ billion); Exhibits41: Chart on Type - Market share 2023-2028 (%); Exhibits42: Data Table on Type - Market share 2023-2028 (%); Exhibits43: Chart on Comparison by Type; Exhibits44: Data Table on Comparison by Type; Exhibits45: Chart on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibits46: Data Table on Prescription - Market size and forecast 2023-2028 ($ billion); Exhibits47: Chart on Prescription - Year-over-year growth 2023-2028 (%); Exhibits48: Data Table on Prescription - Year-over-year growth 2023-2028 (%); Exhibits49: Chart on Non-prescription - Market size and forecast 2023-2028 ($ billion); Exhibits50: Data Table on Non-prescription - Market size and forecast 2023-2028 ($ billion); Exhibits51: Chart on Non-prescription - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Non-prescription - Year-over-year growth 2023-2028 (%); Exhibits53: Market opportunity by Type ($ billion); Exhibits54: Data Table on Market opportunity by Type ($ billion); Exhibits55: Chart on Therapy Area - Market share 2023-2028 (%); Exhibits56: Data Table on Therapy Area - Market share 2023-2028 (%); Exhibits57: Chart on Comparison by Therapy Area; Exhibits58: Data Table on Comparison by Therapy Area; Exhibits59: Chart on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion); Exhibits60: Data Table on Musculoskeletal system - Market size and forecast 2023-2028 ($ billion); Exhibits61: Chart on Musculoskeletal system - Year-over-year growth 2023-2028 (%); Exhibits62: Data Table on Musculoskeletal system - Year-over-year growth 2023-2028 (%); Exhibits63: Chart on Nervous system - Market size and forecast 2023-2028 ($ billion); Exhibits64: Data Table on Nervous system - Market size and forecast 2023-2028 ($ billion); Exhibits65: Chart on Nervous system - Year-over-year growth 2023-2028 (%); Exhibits66: Data Table on Nervous system - Year-over-year growth 2023-2028 (%); Exhibits67: Chart on Respiratory system - Market size and forecast 2023-2028 ($ billion); Exhibits68: Data Table on Respiratory system - Market size and forecast 2023-2028 ($ billion); Exhibits69: Chart on Respiratory system - Year-over-year growth 2023-2028 (%); Exhibits70: Data Table on Respiratory system - Year-over-year growth 2023-2028 (%); Exhibits71: Chart on Others - Market size and forecast 2023-2028 ($ billion); Exhibits72: Data Table on Others - Market size and forecast 2023-2028 ($ billion); Exhibits73: Chart on Others - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Others - Year-over-year growth 2023-2028 (%); Exhibits75: Market opportunity by Therapy Area ($ billion); Exhibits76: Data Table on Market opportunity by Therapy Area ($ billion); Exhibits77: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits78: Impact of drivers and challenges in 2023 and 2028; Exhibits79: Overview on Criticality of inputs and Factors of differentiation; Exhibits80: Overview on factors of disruption; Exhibits81: Impact of key risks on business; Exhibits82: Vendors covered; Exhibits83: Matrix on vendor position and classification; Exhibits84: Abbott Laboratories - Overview; Exhibits85: Abbott Laboratories - Business segments; Exhibits86: Abbott Laboratories - Key offerings; Exhibits87: Abbott Laboratories - Segment focus; Exhibits88: AbbVie Inc. - Overview; Exhibits89: AbbVie Inc. - Product / Service; Exhibits90: AbbVie Inc. - Key news; Exhibits91: AbbVie Inc. - Key offerings; Exhibits92: AstraZeneca PLC - Overview; Exhibits93: AstraZeneca PLC - Product / Service; Exhibits94: AstraZeneca PLC - Key news; Exhibits95: AstraZeneca PLC - Key offerings; Exhibits96: Bayer AG - Overview; Exhibits97: Bayer AG - Business segments; Exhibits98: Bayer AG - Key news; Exhibits99: Bayer AG - Key offerings; Exhibits100: Bayer AG - Segment focus; Exhibits101: Boehringer Ingelheim International GmbH - Overview; Exhibits102: Boehringer Ingelheim International GmbH - Business segments; Exhibits103: Boehringer Ingelheim International GmbH - Key news; Exhibits104: Boehringer Ingelheim International GmbH - Key offerings; Exhibits105: Boehringer Ingelheim International GmbH - Segment focus; Exhibits106: Bristol-Myers Squibb Company - Overview; Exhibits107: Bristol-Myers Squibb Company - Product / Service; Exhibits108: Bristol-Myers Squibb Company - Key news; Exhibits109: Bristol-Myers Squibb Company - Key offerings; Exhibits110: Eli Lilly and Co. - Overview; Exhibits111: Eli Lilly and Co. - Product / Service; Exhibits112: Eli Lilly and Co. - Key news; Exhibits113: Eli Lilly and Co. - Key offerings; Exhibits114: F. Hoffmann La Roche Ltd. - Overview; Exhibits115: F. Hoffmann La Roche Ltd. - Business segments; Exhibits116: F. Hoffmann La Roche Ltd. - Key news; Exhibits117: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits118: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits119: GlaxoSmithKline Plc - Overview; Exhibits120: GlaxoSmithKline Plc - Business segments; Exhibits121: GlaxoSmithKline Plc - Key news; Exhibits122: GlaxoSmithKline Plc - Key offerings; Exhibits123: GlaxoSmithKline Plc - Segment focus; Exhibits124: Johnson and Johnson Services Inc. - Overview; Exhibits125: Johnson and Johnson Services Inc. - Business segments; Exhibits126: Johnson and Johnson Services Inc. - Key news; Exhibits127: Johnson and Johnson Services Inc. - Key offerings; Exhibits128: Johnson and Johnson Services Inc. - Segment focus; Exhibits129: Merck and Co. Inc. - Overview; Exhibits130: Merck and Co. Inc. - Business segments; Exhibits131: Merck and Co. Inc. - Key news; Exhibits132: Merck and Co. Inc. - Key offerings; Exhibits133: Merck and Co. Inc. - Segment focus; Exhibits134: Novartis AG - Overview; Exhibits135: Novartis AG - Business segments; Exhibits136: Novartis AG - Key news; Exhibits137: Novartis AG - Key offerings; Exhibits138: Novartis AG - Segment focus; Exhibits139: Pfizer Inc. - Overview; Exhibits140: Pfizer Inc. - Product / Service; Exhibits141: Pfizer Inc. - Key news; Exhibits142: Pfizer Inc. - Key offerings; Exhibits143: Sanofi SA - Overview; Exhibits144: Sanofi SA - Business segments; Exhibits145: Sanofi SA - Key news; Exhibits146: Sanofi SA - Key offerings; Exhibits147: Sanofi SA - Segment focus; Exhibits148: Teva Pharmaceutical Industries Ltd. - Overview; Exhibits149: Teva Pharmaceutical Industries Ltd. - Business segments; Exhibits150: Teva Pharmaceutical Industries Ltd. - Key news; Exhibits151: Teva Pharmaceutical Industries Ltd. - Key offerings; Exhibits152: Teva Pharmaceutical Industries Ltd. - Segment focus; Exhibits153: Inclusions checklist; Exhibits154: Exclusions checklist; Exhibits155: Currency conversion rates for US$; Exhibits156: Research methodology; Exhibits157: Validation techniques employed for market sizing; Exhibits158: Information sources; Exhibits159: List of abbreviations